Work

Abstract P3-06-36: Assessment of phosphorylated HER2 protein as predictive biomarker to stratify anti-HER2 treatment in HER2 non-amplified patients – A translational study in the GeparQuattro and GeparQuinto trials

Year: 2015

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.sabcs14-p3-06-36

Authors: Stefanie Avril, Gunter von Minckwitz, Sibylle Gündisch, Stephan Gade, Katharina Malinowsky, Peter A Fasching, Thomas Karn, Arndt Hartmann, Michael Untch, Carsten Denkert, Karl-Friedrich Becker, Sibylle Loibl

Institutions: University Hospitals Cleveland Medical Center, Technical University of Munich, German Breast Group, Universitätsklinikum Erlangen, Comprehensive Cancer Center Erlangen, University Hospital Frankfurt, Helios Hospital Berlin-Buch, Charité - Universitätsmedizin Berlin

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W1879286244

Cites:

Cited by: 1

Related to: 10